Inspire Pharmaceuticals reports results of two AZASITE Phase 2 clinical trials for blepharitis
Links shared publicly online about this topic.
- 1,312total visits
Inspire Pharmaceuticals reports results of two AZASITE Phase 2 clinical trials for blepharitis
Inspire Pharmaceuticals, Inc. announced today the results from two Phase 2 clinical trials with AZASITE (azithromycin ophthalmic solution) 1% for the treatment of blepharitis. Inspire will conduct additional clinical work to continue pursuing a potential indication for treatment of anterior and posterior forms of blepharitis.
View full resource at news-medical.net
Tags: Eyelid Disorder, Pharma, Phase 2 Clinical Trial, Clinical Trial, Antibiotic, Zithromax, Zmax
Most Recently Shared on March 16, 2010 at 1:21 am By:
Hygiene updates - Inspire Pharmaceuticals reports results of two AZASITE Phase 2 clinical trials for blepharitis http://ow.ly/16OnlX
Inspire Announces Results From AZASITE(R) Phase 2 Blepharitis Trials And Plans To Continue Clinical Development In Anterior And Posterior Blepharitis
medicalnewstoday.com — “Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced the results from two Phase 2 clinical trials with AZASITE (azithromycin ophthalmic solution) 1% for the treatment of blepharitis. Inspire wil” View full resource at medicalnewstoday.com
Most Recently Shared on March 17, 2010 at 1:21 pm By:
Inspire Announces Results From AZASITE(R) Phase 2 Blepharitis Trials And Plans To Continue Clinical Development In Ant... http://mnt.to/3z2x
Advertisement
